Original Research ArticleA multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability
Under a Creative Commons license
open access
Keywords
antidrug antibodies
enzyme replacement therapy
imiglucerase
type 1 Gaucher disease
velaglucerase alfa
Cited by (0)
© 2014, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics